Prothea Technologies
PrivateLast Round
Series A
Apr 9, 2024
Total Funding Raised
$13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Prothea Technologies is a medical technology company that is developing an integrated diagnostic and treatment platform for lung cancer to enable biopsy and treatment in a single hospital visit.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prothea Technologies Comparables
Compare Prothea Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LEADOPTIK | 82% | |
| Prana Surgical | 78% | |
| Body Vision Medical | 78% |
Prothea Technologies Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Prothea Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korys | Series A |
| Old College Capital | Series A |
| NRW.Bank | Series A |
| Earlybird Venture Capital | Series A |
| Mérieux Equity Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 872% MoM, from 58 to 564.
- Jul 17, 2026
Grew 22% QoQ, from 18 to 22 employees.
Prothea Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Prothea Technologies's valuation, stock price, and market status.
Is Prothea Technologies a public or private company?
Prothea Technologies is a private company.
What is the current stock price of Prothea Technologies?
Prothea Technologies is a private company, so its shares have no public market price. Caplight tracks Prothea Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prothea Technologies worth (valuation)?
Valuation information for Prothea Technologies is not publicly available.
Can I buy Prothea Technologies stock?
Prothea Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prothea Technologies's last funding round?
Prothea Technologies's most recent funding round was Series A on April 9, 2024.
Who are the main investors in Prothea Technologies?
Key investors in Prothea Technologies include Earlybird Venture Capital, Mérieux Equity Partners.
Will Prothea Technologies IPO soon?
No public IPO plans have been announced for Prothea Technologies.
How can I track Prothea Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Prothea Technologies's shares on secondary markets.